
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Market cap
$224m
Enterprise value
($20m)
Share price
$15.13 MACK
Authorizing premium user...